Joint Bone Spine

Article	Citations
Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: A population-based study in the first two months of COVID-19 outbrea	67
Chronic pain and neuroinflammation	52
2020 recommendations from the French Society of Rheumatology for the management of gout: Urate-lowering therapy	47
2022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritis	47
Rheumatoid arthritis risk in periodontitis patients: A systematic review and meta-analysis	45
Rheumatoid arthritis and depression	45
Recommendations of the French Society of Rheumatology on pharmacological treatment of knee osteoarthritis	44
Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome	43
COVID-19 in French patients with chronic inflammatory rheumatic diseases: Clinical features, risk factors and treatment adherence	40
2020 French recommendations on the management of septic arthritis in an adult native joint	40
The role of interleukin-1 family members in hyperuricemia and gout	37
Metabolomics in the development and progression of rheumatoid arthritis: A systematic review	37
Dietary recommendations of the French Society for Rheumatology for patients with chronic inflammatory rheumatic diseases	36
Risk of venous thromboembolism in rheumatoid arthritis	30
Clinical guidelines and care pathway for management of low back pain with or without radicular pain	29
Implications of COVID-19 for the management of patients with inflammatory rheumatic diseases	29
Osteoporosis in older adults	28
Systemic sclerosis: Recent insight in clinical management	28
Effects of prior osteoporosis treatment on 12-month treatment response of romosozumab in patients with postmenopausal osteoporosis	27
Gender-related differences in disease activity and clinical features in patients with peripheral psoriatic arthritis: A multi-center study	27
Granulomatosis with polyangiitis (Wegener's)	26
A critical review of weight loss recommendations before total knee arthroplasty	26
Cardiovascular risk in psoriatic arthritis, a narrative review	26
Neuropathic pain and symptoms of potential small-fiber neuropathy in fibromyalgic patients: A national on-line survey	24
Association between benzodiazepines use and risk of hip fracture in the elderly people: A meta-analysis of observational studies	24

Can SARS-CoV-2 trigger reactive arthritis?	24
Old and new antirheumatic drugs for the treatment of COVID-19	23
Treatment adherence during the COVID-19 pandemic and the impact of confinement on disease activity and emotional status: A survey in 644 rheumatic patients	22
The DIGICOD cohort: A hospital-based observational prospective cohort of patients with hand osteoarthritis – methodology and baseline characteristics of the population	22
Polymyalgia rheumatica following COVID-19 vaccination: A case-series of ten patients	21
COPA syndrome, 5 years after: Where are we?	21
SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID-19 vaccine shot as a trigger? Comment on: “Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?” by Manzo et al. Joint Bone Spin	20
Efficacy of intra-articular corticosteroid injections in knee osteoarthritis: A systematic review and meta-analysis of randomized controlled trials	20
Vagus nerve stimulation in musculoskeletal diseases	20
Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020	19
Trained immunity and inflammation in rheumatic diseases	19
Hydroxychloroquine in systemic and autoimmune diseases: Where are we now?	18
New biologics and targeted therapies in systemic lupus: From new molecular targets to new indications. A systematic review	18
Osteoarthritis: From upcoming treatments to treatments yet to come	17
CoVid-19 related dactyitis	17
Coexistence of immune-mediated diseases in sarcoidosis. Frequency and clinical significance in 1737 patients	17
High patient global assessment scores in patients with rheumatoid arthritis otherwise in remission do not reflect subclinical inflammation	17
Physical activity for osteoarthritis: Efficiency and review of recommandations	16
2020 Recommendations from the French Society of Rheumatology for the management of gout: Management of acute flares	16
The challenge of differentiating fibromyalgia from small-fiber neuropathy in clinical practice	16
Autophagy and bone diseases	16
UltraSound evaluation in follow-up of urate-lowering therapy in gout phase 2 (USEFUL-2): Duration of flare prophylaxis	15
Origins of rheumatoid arthritis	15
Central Sensitization Inventory is a useless instrument for detection of the impairment of the conditioned pain modulation in patients with chronic musculoskeletal pain	15
Physical activity in the treatment of fibromyalgia	15
Antigen-specific tolerance approach for rheumatoid arthritis: Past, present and future	14
Fake news: Why do we believe it?	14
Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?	14
Trends in the manifestations of 9754 gout patients in a Chinese clinical center: A 10-year observational study	14
Elderly-onset primary Sjögren's syndrome focused on clinical and salivary gland ultrasonographic features	14
Bronchiectasis in rheumatoid arthritis. A clinical appraisial	14
Golimumab effectiveness in biologic inadequate responding patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis in real-life from the Italian registry GISEA	14
Role of HLA-B27 in the comorbidities observed in Axial Spondyloarthritis: Data from COMOSPA	14
X-linked hypophosphatemia and burosumab: Practical clinical points from the French experience	14
Determinants of sleep impairment in psoriatic arthritis: An observational study with 396 patients from 14 countries	14
A 12-point recommendation framework to support advancement of the multidisciplinary care of psoriatic arthritis: A call to action	14
New insights into macrophage heterogeneity in rheumatoid arthritis	13
Denosumab in the management of Aneurysmal bone cyst	13
The updated GRAPPA and EULAR recommendations for the management of psoriatic arthritis: Similarities and differences	13
Extended myositis-specific and -associated antibodies profile in systemic sclerosis: A cross-sectional study	13
Local sacroiliac injections in the treatment of spondyloarthritis. What is the evidence?	13
Ethnic influence on the phenotype of French patients with systemic sclerosis	13
Assessing central sensitization with quantitative sensory testing in inflammatory rheumatic diseases: A systematic review	13
Palindromic rheumatism: Evidence of four subtypes of palindromic-like arthritis based in either MEFV or rheumatoid factor/ACPA status	13
The relationship between weight status and metabolic syndrome in patients with rheumatoid arthritis and spondyloarthritis	13
Data to be collected for an optimal management of axial spondyloarthritis in daily practice: Proposal from evidence-based and consensual approaches	13
Performance of a new rapid diagnostic test the lactate/glucose ratio of synovial fluid for the diagnosis of septic arthritis	12
Evolution of hydrogels for cartilage tissue engineering of the knee: A systematic review and meta-analysis of clinical studies	12
Safety and efficacy of adipose-derived mesenchymal stem cells for knee osteoarthritis: A systematic review and m-analysis	12
Predictors of fatal and non-fatal cardiovascular events in ANCA-associated vasculitis: Data from the Toronto CanVasc cohort	12

Frailty in rheumatoid arthritis: A systematic review and meta-analysis	12
Fast track clinic for early diagnosis of polymyalgia rheumatica: Impact on symptom duration and prednisolone initiation	12
Effectiveness and safety of tocilizumab in patients with refractory or severe Takayasu's arteritis: A prospective cohort study in a Chinese population	12
Epidemiology of cutaneous involvement in Sjögren syndrome: Data from three French pSS populations (TEARS, ASSESS, diapSS)	12
Anakinra compared to prednisone in the treatment of acute CPPD crystal arthritis: A randomized controlled double-blinded pilot study	12
Ultrasound prevalence of wrist, hand, ankle and foot synovitis and tenosynovitis in systemic sclerosis, and relationship with disease features and hand disability	11
Fibrosing interstitial lung disease in primary Sjogren syndrome	11
Contribution of mycobiota to the pathogenesis of spondyloarthritis	11
All-cause and cause-specific mortality of patients with rheumatoid arthritis in Korea: A nation-wide population-based study	11
Evaluation of febuxostat initiation during an acute gout attack: A prospective, randomized clinical trial	11
Neuralgic amyotrophy and COVID-19 infection: 2 cases of spinal accessory nerve palsy	11
Progress towards improved non-pharmacological management of fibromyalgia	11
Muscle involvement on 18F-FDG PET-CT in polymyalgia rheumatica. A controlled retrospective study of 101 patients	11
Patients with axial spondyloarthritis report significant differences between men and women and high impact of the disease: Large websurvey analysis	10
Cognitive impairment in patients with rheumatoid arthritis: A systematic review and meta-analysis	10
Predictors of mortality in rheumatoid arthritis-associated lung disease: A retrospective study on ten years	10
Inconsistencies of the Disease Activity Assessment Tools for Psoriatic Arthritis: Challenges to Rheumatologists	10
Dupuytren's Disease and exposure to vibration: Systematic review and Meta-analysis	10
Particulate matter (PM10) as a newly identified environmental risk factor for acute gout flares: A time-series study	10
Toward a tailored therapeutic prescription for patients with axial spondyloarthritis	10
Bone changes in early inflammatory arthritis assessed with High-Resolution peripheral Quantitative Computed Tomography (HR-pQCT): A 12-month cohort study	10
Osteoarthritis and gut microbiome	10
Osteoarthritis and incidence of stroke and transient ischemic attack in 320,136 adults followed in general practices in the United Kingdom	9
Acromegaly is associated with vertebral deformations but not vertebral fractures: Results of a cross-sectional monocentric study	9
Bone and primary hyperparathyroidism	9
Diagnostic performance of sacroiliac and spinal MRI for the diagnosis of non-radiographic axial spondyloarthritis in patients with inflammatory back pain	9
Epigenetics of spondyloarthritis	9
Is it possible to stop glucocorticoids in systemic lupus?	9
Targets of hydroxychloroquine in the treatment of rheumatoid arthritis. A network pharmacology study	9
COVID-19 epidemiology in rheumatic diseases in Tuscany: A case-control study	9
Imminent fracture risk	9
Venous congestion as a central mechanism of radiculopathies	9
Impact of key manifestations of psoriatic arthritis on patient quality of life, functional status, and work productivity: Findings from a real-world study in the United States and Europe	9
Recommendations for the pragmatic use of ultrasound in rheumatoid arthritis by the GEISPER French group	9
Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio reflect disease activity and flares in patients with systemic lupus erythematosus – A prospective study	8
Current and future treatment in primary Sjögren's syndrome – A still challenging development	8
The impact of osteoporosis and vertebral compression fractures on mortality and association with pulmonary function in COPD: A meta-analysis	8
World mortality of ankylosing spondylitis, psoriatic arthritis and inflammatory bowel disease in 2015 and its evolution from 2001 to 2015	8
Effect of disease-modifying anti-rheumatic drugs in osteoarthritis: A meta-analysis	8
Early discontinuation of tofacitinib in patients with rheumatoid arthritis co-treated with rifampin for latent tuberculosis	8
Efficacy of baricitinib on periodontal inflammation in patients with rheumatoid arthritis	8
Presence of spondyloarthritis associated to higher disease activity and HLA-B27 positivity in patients with early Crohn's disease: Clinical and MRI results from a prospective inception cohort	8
Spondyloarthritis and sarcoidosis: Related or fake friends? A systematic literature review	8
Roles of osteoclast-associated receptor in rheumatoid arthritis and osteoarthritis	8
Adherence to hydroxychloroquine in patients with systemic lupus: Contrasting results and weak correlation between assessment tools	8
Management of patients with rheumatoid arthritis by telemedicine: connected monitoring. A randomized controlled trial	8
Physical activity and quality of life of patients with rheumatoid arthritis at the time of COVID-19 lockdown: an online patient survey	8
Is the Difficult-to-Treat (D2T) concept applicable to axial spondyloarthritis?	8
HLA association with the susceptibility to anti-synthetase syndrome	8
Epidemiology of gout and hyperuricemia in New Caledonia	8
Use of 18F FDG PET-CT to discriminate polymyalgia rheumatica and atypical spondylarthritis in clinical practice	8
High prevalence of salivary gland ultrasound abnormalities in systemic sclerosis	8
Practical management of patients on hydroxychloroquine	8
Interaction of TNFi and conventional synthetic DMARD in SARS-CoV-2 vaccine response in axial spondyloarthritis and psoriatic arthritis	8
Tight control and treat-to-target in axial spondyloarthritis. Where are we?	7
How and why are rheumatologists relevant to COVID-19?	7
Pregnancy rates and outcomes in early axial spondyloarthritis: An analysis of the DESIR cohort	7
Dietary recommendations in the prevention and treatment of osteoporosis	7
Biological therapy in refractory chronic nonbacterial osteomyelitis: A case series of 19 patients	7
Predictors of disease flare after discontinuation of concomitant methotrexate in Japanese patients with rheumatoid arthritis treated with tocilizumab	7
Rheumatoid arthritis and cognitive decline	7
Are the recommendations for the use of anti-TNF drugs during axial spondyloarthritis relevant for non-radiographic forms?	7
Lyme disease: “End of the debate?”	7
Adjuvant-induced arthritis is a relevant model to mimic coronary and myocardial impairments in rheumatoid arthritis	7
Squamous cell carcinoma antigen-IgM (SCCA-IgM) is associated with interstitial lung disease in systemic sclerosis	7
Janus kinases inhibitors for treating patients with rhupus	7
Age- and sex-specific effects of obesity, metabolic syndrome and its components on back pain: The English Longitudinal Study of Ageing	7
Serological response to SARS-CoV-2 vaccination in patients with inflammatory rheumatic disease treated with disease modifying anti-rheumatic drugs: A cohort study and a meta-analysis	7
“Y” sign in spinal epidural lipomatosis	6
Chronic bursitis and tenosynovitis revealing Whipple's disease	6
The relationship between kinesiophobia and health-related quality of life in patients with rheumatoid arthritis: A controlled cross-sectional study	6
SARS CoV-2 vaccine AND rituximab, timing might be a key for a better vaccine response	6
Polyarteritis Nodosa: State of the art	6
Clinical and prognostic significance of antinuclear antibodies in primary antiphospholipid syndrome: A multicenter retrospective study	6
Engineered glove to evaluate hand disability in rheumatoid arthritis: A pilot-study	6
Sex differences in clinical characteristics and their influence on clinical outcomes in an observational cohort of patients with rheumatoid arthritis	6
Otolaryngologic manifestations of diffuse idiopathic skeletal hyperostosis (Forestier's disease): A systematic review of the literature	6
Sonographic assessment of calcium pyrophosphate deposition disease at wrist. A focus on the dorsal scapho-lunate ligament	6
Cobalt hip prosthesis intoxication mimicking an autoimmune disease	6
Dual energy computed tomography: A breakthrough for gout?	6

Tissue microbiota: A ‘secondary-self’, first target of autoimmunity?	6
Mitral valve granulomatosis: A paradoxical reaction complicating etanercept treatment in rheumatoid arthritis. A case report	6
Consequences of spinal ankylosis on bone trabecular fragility assessed on CT scans in patients with ankylosing spondylitis. A retrospective study	6
Spine abnormalities associated with bone edema on sacroiliac joints MRI in patients with non-inflammatory chronic back pain	6
Correspondence between patient-reported flare and disease activity score variation in axial spondyloarthritis: A 12-months web-based study	6
Aortic involvement in giant cell arteritis	6
Inpatient burden and resource utilization of polymyositis and dermatomyositis: A 10-year Study of National Inpatient Sample	6
Aromatase inhibitor-induced inflammatory myopathies: A case series	6
Over-treatment in rheumatology	6
Rheumatic and musculoskeletal disorders induced by immune checkpoint inhibitors: Consequences on overall survival	6
Can we use artificial intelligence for systematic literature review in rheumatology?	6
Diagnostic value of cardiac natriuretic peptide on pulmonary hypertension in systemic sclerosis: A systematic review and meta-analysis	6
Incidence and risk of developing rheumatic diseases in 19,724 patients with palindromic rheumatism in South Korea: A nationwide population-based study	6
How to taper glucocorticoids in inflammatory rheumatic diseases? A narrative review of novel evidence in rheumatoid arthritis, systemic lupus erythematosus, and giant cell arteritis	6
Temporal arteritis in IgG4 related disease	6
Time to initiation of biologic disease-modifying antirheumatic drugs in the French cohort ESPOIR	6
Treatment of Trigger finger by ultrasound-guided needle release of a1 pulley: A series of 105 cases	6
Is methotrexate contra-indicated in lung involvement of rheumatoid arthritis?	6
Application of artificial intelligence to imaging interpretations in the musculoskeletal area: Where are we? Where are we going?	5
Time trends in in-hospital mortality reduction in vasculitis vs. non-vasculitis hospitalisations vary by patient sex and age	5
Appropriateness of laboratory tests in the diagnosis of inflammatory rheumatic diseases among patients newly referred to rheumatologists	5
The exposome in rheumatoid arthritis	5
Suicidal ideation and suicide attempt associated with antidepressant and antiepileptic drugs: Implications for treatment of chronic pain	5
Patients’ safety skills assessment with biologics and JAK inhibitors: Update of the BioSecure questionnaire	5
Factors associated with drug-free remission at 5-year in early onset axial spondyloarthritis patients: Data from the DESIR cohort	5
Can machine learning models support physicians in systemic lupus erythematosus diagnosis? Results from a monocentric cohort	5
Denosumab in active Charcot neuro-osteoarthropathy of the foot	5
The impact of diet on disease activity in spondyloarthritis: A systematic literature review	5
Skin necrosis following intra-articular hyaluronic acid injection in the knee of a 63-year-old male	5
Drastic monosodium urate crystal dissolution with febuxostat and benzbromarone	5
Preventive interventions in individuals at risk for Rheumatoid Arthritis: State of the art and perspectives	5
Intravenous anakinra to curb cytokine storm in adult-onset Still's disease and in macrophage activation syndrome: A case series	5
A case of Whipple's disease mimicking auto-inflammatory disease and revealed by severe right cardiac failure under anakinra	5
Association between dermatoporosis and history of major osteoporotic fractures: A French prospective observational study in a general practice population	5
Leptomeningeal involvement in a patient with systemic lupus erythematosus infected by COVID-19	5
Analysis of vascular involvement in 460 patients with Behçet's syndrome: Clinical characteristics and associated factors	5
Tocilizumab controls bone turnover in early polymyalgia rheumatica	5
Epidemiology and predictors of relapse in giant cell arteritis: A systematic review and meta-analysis	5
Attainment of the Patient-acceptable Symptom State in 548 patients with rheumatoid arthritis: Influence of demographic factors	5
Prevalence, mortality, and treatment of patients with rheumatoid arthritis: A cohort study of the French National Health Data System, 2010–2019	5
Comparison of paediatric and adult classification criteria in juvenile idiopathic arthritis during the transition from paediatric to adult care	5
A possibly new autoinflammatory disease due to compound heterozygous phosphomevalonate kinase gene mutation	5